Remove 2019 Remove Data Entry Remove Labelling
article thumbnail

Deviation investigation guidelines in the pharmaceutical industry

GMPSOP

In the five years between 2019 and 2023, the FDA issued the following warning letters, closely related to ineffective deviation investigation. Packaging/labeling/Misbranding: 41 warnings vi. In 2019 and 2020, warning letters were issued for “Adulterated Food and Supplements” at 36% and 33%, respectively. incorrect data entry).